Celsion (CLSN) Tops Q2 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CHKP
6. CRWD
7. ON
8. INSP
9. HNGE
10. AMD

Go back to Celsion (CLSN) Tops Q2 EPS by 4c

Celsion (CLSN) Announces Expansion of EAP for ThermoDox with myTomorrows

August 10, 2015 8:31 AM EDT

Celsion (NASDAQ: CLSN) announced that it has expanded its Early Access Program (EAP) for lyso-thermosensitive liposomal doxorubicin (LTLD), referred to by Celsion as ThermoDox®, with myTomorrows to include patients with primary liver cancer, also known as hepatocellular carcinoma (HCC) and liver cancer metastases, in all countries of the European Union (EU) territory, Switzerland, Turkey and Israel. The Company's original European EAP with myTomorrows, formed in January 2015, provides eligible patients with access to LTLD for the treatment of recurrent chest wall (RCW) breast cancer. The EAP for LTLD was launched in the second quarter. LTLD is Celsion's... More